Puma Biotechnology Inc (PBYI)
2.985
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 14, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Total Liabilities (Quarterly): 149.63M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 149.63M |
| June 30, 2024 | 156.49M |
| March 31, 2024 | 163.17M |
| December 31, 2023 | 177.09M |
| September 30, 2023 | 164.86M |
| June 30, 2023 | 170.10M |
| March 31, 2023 | 170.41M |
| December 31, 2022 | 200.45M |
| September 30, 2022 | 176.62M |
| June 30, 2022 | 173.91M |
| March 31, 2022 | 193.54M |
| December 31, 2021 | 229.03M |
| September 30, 2021 | 237.21M |
| June 30, 2021 | 230.53M |
| March 31, 2021 | 242.22M |
| December 31, 2020 | 250.17M |
| September 30, 2020 | 262.15M |
| June 30, 2020 | 240.41M |
| March 31, 2020 | 216.15M |
| December 31, 2019 | 217.44M |
| September 30, 2019 | 214.86M |
| June 30, 2019 | 218.09M |
| March 31, 2019 | 287.88M |
| December 31, 2018 | 224.82M |
| September 30, 2018 | 184.81M |
| Date | Value |
|---|---|
| June 30, 2018 | 189.32M |
| March 31, 2018 | 112.18M |
| December 31, 2017 | 112.22M |
| September 30, 2017 | 102.69M |
| June 30, 2017 | 52.71M |
| March 31, 2017 | 49.23M |
| December 31, 2016 | 42.97M |
| September 30, 2016 | 42.88M |
| June 30, 2016 | 43.82M |
| March 31, 2016 | 40.23M |
| December 31, 2015 | 33.84M |
| September 30, 2015 | 26.78M |
| June 30, 2015 | 27.58M |
| March 31, 2015 | 27.55M |
| December 31, 2014 | 45.71M |
| September 30, 2014 | 30.45M |
| June 30, 2014 | 29.04M |
| March 31, 2014 | 21.47M |
| December 31, 2013 | 20.39M |
| September 30, 2013 | 20.35M |
| June 30, 2013 | 20.96M |
| March 31, 2013 | 22.74M |
| December 31, 2012 | 22.79M |
| September 30, 2012 | 27.49M |
| June 30, 2012 | 16.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
149.63M
Minimum
Sep 2024
262.15M
Maximum
Sep 2020
201.08M
Average
197.00M
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.72M |
| Shareholders Equity (Quarterly) | 71.09M |
| Debt to Equity Ratio | 1.098 |
| Current Ratio | 1.420 |
| Net Debt Paydown Yield | 3.34% |